Burkina Faso vs Hong Kong: HIV-positive TB patients on ART (antiretroviral therapy)
Burkina Faso
100.0%
in 2024
Hong Kong
100.0%
in 2024
Burkina Faso rank
1st
Hong Kong rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Burkina Faso
- Hong Kong
How they compare
Burkina Faso currently reports 100.0% against 100.0% in Hong Kong, a difference of 0.0%.
The two have swapped places 4 times across 16 shared years of data; in 2005 it was Hong Kong ahead.
Burkina Faso ranks 1st and Hong Kong ranks 1st of 144 countries.
Across the 3 decades both report, Burkina Faso averaged higher in 2 and Hong Kong in 1.
Head to head by decade
| Decade | Burkina Faso | Hong Kong | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.6% | 44.8% | 0.2% | Hong Kong |
| 2010s | 80.5% | 31.1% | 49.4% | Burkina Faso |
| 2020s | 94.2% | 92.2% | 2.0% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Burkina Faso or Hong Kong?
- Burkina Faso, at 100.0% against 100.0% in Hong Kong as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Burkina Faso and Hong Kong?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Hong Kong?
- 16 years are reported by both, from 2005 to 2024.
- How do Burkina Faso and Hong Kong rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Burkina Faso ranks 1st and Hong Kong ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.